Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 27.82%647.37M | 27.99%432.54M | 36.40%298.11M | 14.25%668.1M | 3.84%506.45M | 7.06%337.95M | 19.63%218.55M | -2.29%584.79M | 7.15%487.7M | 7.07%315.67M |
| Refunds of taxes and levies | 855.08%186.99M | 1,040.72%131.48M | 226.44%7.21M | 20.62%27.92M | 28.24%19.58M | 21.55%11.53M | -43.35%2.21M | 4.49%23.14M | -6.85%15.27M | -1.09%9.48M |
| Cash received relating to other operating activities | 1,087.66%421.26M | 1,899.40%213.24M | 239.05%22.47M | 198.38%55.79M | 118.32%35.47M | 25.42%10.67M | 46.87%6.63M | -6.73%18.7M | -15.26%16.25M | -49.89%8.5M |
| Cash inflows from operating activities | 123.62%1.26B | 115.82%777.26M | 44.16%327.79M | 19.98%751.81M | 8.14%561.5M | 7.94%360.14M | 18.99%227.39M | -2.19%626.63M | 5.81%519.22M | 3.82%333.65M |
| Goods services cash paid | 55.24%487.34M | 98.42%297.53M | 36.54%116.94M | 51.65%399.24M | 30.35%313.93M | 7.78%149.95M | 18.92%85.64M | -45.03%263.26M | -36.84%240.83M | -41.76%139.12M |
| Staff behalf paid | 10.60%178.81M | 23.15%135.87M | 28.15%67.47M | 51.39%226.13M | 47.70%161.68M | 35.00%110.33M | 27.00%52.65M | 4.72%149.36M | -1.19%109.46M | -0.58%81.73M |
| All taxes paid | 8.09%61.35M | 2.02%44.81M | 5.80%12.24M | 21.61%64.81M | 10.16%56.76M | 3.27%43.92M | -9.90%11.57M | 19.90%53.3M | 35.86%51.53M | 45.95%42.53M |
| Cash paid relating to other operating activities | 179.21%80.01M | 288.79%69.28M | 219.35%32.74M | 31.62%54.18M | -40.99%28.65M | -29.13%17.82M | -39.62%10.25M | 69.90%41.17M | 133.09%48.56M | 12.79%25.14M |
| Adjustment items of operating cash outflws | ---- | --0.01 | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from operating activities | 43.94%807.51M | 70.02%547.49M | 43.27%229.39M | 46.79%744.36M | 24.57%561.02M | 11.61%322.02M | 11.74%160.12M | -26.53%507.09M | -18.23%450.37M | -22.55%288.52M |
| Adjustment items of net operating cash flow | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash flows from operating activities | 92,755.37%448.11M | 502.81%229.77M | 46.28%98.4M | -93.77%7.45M | -99.30%482.59K | -15.55%38.12M | 40.74%67.27M | 341.12%119.54M | 214.56%68.85M | 188.29%45.13M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --106.44K | --106.44K | --106.44K | --74.59M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | ---- | ---- | ---- | -93.82%341.74K | -93.34%341.74K | -90.57%337.65K | ---- | -59.22%5.53M | -52.29%5.13M | -48.65%3.58M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 567.60%2.75M | -92.28%10.28K | ---- | -63.80%448.9K | 71.84%412.41K | 77.45%133.09K | -32.05%50.96K | -4.18%1.24M | -78.84%240K | -93.12%75K |
| Cash received relating to other investing activities | 82.83%64.97M | 92.89%64.97M | 51.72%30.36M | -48.76%244.89M | -84.19%35.53M | -66.32%33.68M | -79.99%20.01M | 64.72%477.95M | -13.80%224.73M | -37.84%100M |
| Cash inflows from investing activities | 86.92%67.83M | 90.58%65.08M | 51.87%30.47M | -33.93%320.27M | -84.23%36.29M | -67.05%34.15M | -80.34%20.06M | 58.92%484.72M | -15.59%230.11M | -38.64%103.65M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -80.97%169.58M | -82.37%154.6M | 3.53%87.67M | 165.13%1.13B | 1,447.41%891.24M | 11,815.54%876.95M | 1,940.25%84.68M | 1,622.31%424.73M | 237.26%57.6M | -48.63%7.36M |
| Cash paid relating to other investing activities | -95.05%5.34M | -91.55%5.27M | -98.31%2.73M | -42.67%132.68M | --107.79M | --62.4M | --161.45M | -3.56%231.45M | ---- | ---- |
| Cash outflows from investing activities | -82.49%174.92M | -82.98%159.87M | -63.27%90.4M | 91.83%1.26B | 1,634.56%999.03M | 12,663.40%939.35M | 5,830.11%246.13M | 147.93%656.18M | -74.64%57.6M | -94.08%7.36M |
| Net cash flows from investing activities | 88.88%-107.09M | 89.53%-94.78M | 73.49%-59.94M | -447.35%-938.51M | -658.08%-962.75M | -1,040.03%-905.2M | -330.94%-226.07M | -524.91%-171.47M | 279.01%172.51M | 115.84%96.29M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --65.24M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30M | ---- | ---- |
| Cash from borrowing | -96.15%20M | -96.15%20M | ---- | 943.40%553M | 812.16%520M | 2,170.23%520M | ---- | -27.40%53M | -21.91%57.01M | -56.78%22.91M |
| Cash received relating to other financing activities | -71.69%153.9M | -68.68%135.8M | -75.83%58M | 151.03%650.8M | 2,723.90%543.6M | 3,513.33%433.6M | --240M | 132.66%259.25M | -82.72%19.25M | -89.23%12M |
| Cash inflows from financing activities | -83.65%173.9M | -83.66%155.8M | -75.83%58M | 218.89%1.2B | 1,294.75%1.06B | 2,631.97%953.6M | --240M | 104.69%377.49M | -58.65%76.26M | -78.77%34.91M |
| Borrowing repayment | 57.43%31.49M | 54.95%30.99M | --495K | -13.70%63M | -72.60%20M | -48.72%20M | ---- | 37.74%73M | 0.80%73M | -46.15%39M |
| Dividend interest payment | -69.84%19.39M | -47.77%12.97M | 1,150.01%6.43M | -13.77%29.07M | 93.62%64.29M | -24.09%24.83M | -26.71%514.3K | 3.15%33.72M | 2.28%33.2M | 2.88%32.71M |
| Cash payments relating to other financing activities | 32,343.41%447.76M | 44,401.47%229.07M | 7.17%286.78K | -71.84%11.05M | -93.36%1.38M | 22.60%514.76K | 51.56%267.6K | -34.73%39.24M | -46.78%20.79M | -95.99%419.87K |
| Adjustment items of financing cash outflows | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 |
| Cash outflows from financing activities | 482.05%498.63M | 502.11%273.03M | 822.18%7.21M | -29.35%103.12M | -32.54%85.67M | -37.14%45.35M | -97.99%781.9K | 0.10%145.96M | -11.78%126.99M | -37.11%72.13M |
| Adjustment items of net financing cash flow | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 |
| Net cash flows from financing activities | -133.21%-324.73M | -112.91%-117.23M | -78.77%50.79M | 375.39%1.1B | 2,027.48%977.93M | 2,539.71%908.25M | 715.30%239.22M | 499.69%231.53M | -225.34%-50.74M | -174.87%-37.23M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 90.77%477.91K | 2,228.13%469.25K | 1,770.10%404.84K | -160.11%-112.68K | 41.17%250.52K | -110.11%-22.05K | 38.84%-24.24K | 45.21%187.46K | -40.49%177.46K | 72.23%218.17K |
| Net increase in cash and cash equivalents | 5.33%16.77M | -55.72%18.22M | 11.53%89.66M | -5.72%169.5M | -91.66%15.92M | -60.59%41.15M | -24.71%80.4M | 509.21%179.8M | 628.36%190.8M | 140.91%104.42M |
| Add:Begin period cash and cash equivalents | 67.98%418.83M | 67.98%418.83M | 67.98%418.83M | 258.58%249.33M | 258.58%249.33M | 258.58%249.33M | 258.58%249.33M | 73.75%69.53M | 73.75%69.53M | 73.75%69.53M |
| End period cash equivalent | 64.22%435.6M | 50.46%437.05M | 54.22%508.49M | 67.98%418.83M | 1.89%265.25M | 66.99%290.48M | 87.02%329.72M | 258.58%249.33M | 293.16%260.33M | 108.67%173.95M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.